lisofylline has been researched along with linoleic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bursten, SL; Chaney, RB; Guidot, DM; Hybertson, BM; Repine, AJ; Repine, JE; Rice, GC; Singer, JW | 1 |
| Frangioudakis, G; Garrard, J; Mitchell, TW; Nadler, JL; Raddatz, K; Schmitz-Peiffer, C | 1 |
| Chitkara, D; Italiya, KS; Mahato, RI; Mazumdar, S; Mittal, A; Sharma, S | 1 |
| Chitkara, D; Italiya, KS; Mittal, A; Singh, AK | 1 |
4 other study(ies) available for lisofylline and linoleic acid
| Article | Year |
|---|---|
Modulating phosphatidic acid metabolism decreases oxidative injury in rat lungs.
Topics: Animals; Chemotaxis, Leukocyte; Humans; Hydrogen Peroxide; Interleukin-8; Linoleic Acid; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oleic Acid; Organ Size; Oxidative Stress; Pentoxifylline; Perfusion; Phosphatidic Acids; Rats; Rats, Sprague-Dawley; Superoxides | 1997 |
Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.
Topics: Animals; Blood Glucose; Body Weight; Cell Line; Ceramides; Dietary Fats; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Glucose Intolerance; Immunosuppressive Agents; Insulin; Linoleic Acid; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myoblasts; Oxidoreductases; Palmitates; Pentoxifylline; Phosphatidic Acids; Triglycerides | 2010 |
Self-assembling lisofylline-fatty acid conjugate for effective treatment of diabetes mellitus.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diabetes Mellitus, Experimental; Inflammation Mediators; Insulin Secretion; Insulinoma; Linoleic Acid; Male; Micelles; Pentoxifylline; Protective Agents; Rats; Rats, Wistar; Tissue Distribution | 2019 |
Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat.
Topics: Administration, Oral; Animals; Cell Line; Cell Survival; Diabetes Mellitus, Type 1; Dosage Forms; Jejunum; Linoleic Acid; Male; Mice; Nanoparticles; Pentoxifylline; Perfusion; Rats; Rats, Wistar; Tablets | 2021 |